SG Americas Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$540M Buy
8,910,032
+6,286,007
+240% +$366M 0.58% 23
2025
Q4
$142M Buy
2,624,025
+949,375
+57% +$45.7M 0.18% 84
2025
Q3
$75.5M Buy
1,674,650
+1,177,732
+237% +$55M 0.25% 52
2025
Q2
$23M Sell
496,918
-137,469
-22% -$6.75M 0.1% 158
2025
Q1
$38.7M Buy
634,387
+468,170
+282% +$27.3M 0.13% 111
2024
Q4
$9.4M Buy
166,217
+100,400
+153% +$5.61M 0.04% 231
2024
Q3
$3.4M Sell
65,817
-1,198,561
-95% -$56.2M 0.01% 523
2024
Q2
$52.5M Sell
1,264,378
-1,667,365
-57% -$74.6M 0.31% 61
2024
Q1
$159M Buy
2,931,743
+1,013,267
+53% +$51.6M 0.76% 16
2023
Q4
$98.4M Buy
1,918,476
+1,666,229
+661% +$87.5M 0.92% 17
2023
Q3
$14.6M Sell
252,247
-588,473
-70% -$36.1M 0.17% 116
2023
Q2
$53.8M Buy
840,720
+340,741
+68% +$22.8M 0.41% 27
2023
Q1
$34.7M Buy
499,979
+142,358
+40% +$10M 0.4% 37
2022
Q4
$25.7M Sell
357,621
-70,469
-16% -$5.31M 0.31% 53
2022
Q3
$30.4M Buy
428,090
+108,506
+34% +$7.87M 0.38% 47
2022
Q2
$24.6M Buy
319,584
+309,457
+3,056% +$23.6M 0.26% 60
2022
Q1
$740K Sell
10,127
-188,583
-95% -$12.7M 0.01% 1629
2021
Q4
$12.4M Buy
198,710
+96,392
+94% +$5.65M 0.07% 225
2021
Q3
$6.05M Buy
102,318
+19,188
+23% +$1.26M 0.03% 453
2021
Q2
$5.55M Sell
83,130
-38,198
-31% -$2.49M 0.03% 546
2021
Q1
$7.66M Sell
121,328
-37,109
-23% -$2.31M 0.04% 364
2020
Q4
$9.83M Sell
158,437
-284,138
-64% -$17.5M 0.05% 266
2020
Q3
$26.7M Buy
442,575
+124,314
+39% +$7.48M 0.17% 87
2020
Q2
$18.7M Buy
318,261
+110,082
+53% +$6.58M 0.16% 105
2020
Q1
$11.6M Sell
208,179
-691,960
-77% -$42.3M 0.11% 161
2019
Q4
$57.8M Buy
900,139
+893,149
+12,778% +$51.2M 0.53% 26
2019
Q3
$354K Sell
6,990
-573,411
-99% -$26.9M ﹤0.01% 2070
2019
Q2
$26.3M Buy
580,401
+223,555
+63% +$10.4M 0.18% 92
2019
Q1
$17M Sell
356,846
-141,423
-28% -$7.04M 0.16% 139
2018
Q4
$25.9M Sell
498,269
-71,857
-13% -$3.86M 0.23% 90
2018
Q3
$35.4M Buy
570,126
+279,989
+97% +$16.6M 0.26% 67
2018
Q2
$16.1M Buy
290,137
+23,572
+9% +$1.27M 0.14% 141
2018
Q1
$16.9M Sell
266,565
-130,385
-33% -$8.39M 0.13% 123
2017
Q4
$24.3M Buy
396,950
+122,175
+44% +$7.64M 0.23% 68
2017
Q3
$17.5M Sell
274,775
-175,286
-39% -$10.2M 0.15% 88
2017
Q2
$25.1M Sell
450,061
-900,125
-67% -$49M 0.23% 91
2017
Q1
$73.4M Buy
1,350,186
+870,836
+182% +$47.8M 0.65% 19
2016
Q4
$28M Buy
479,350
+363,049
+312% +$19.8M 0.24% 84
2016
Q3
$6.27M Sell
116,301
-531
-0.5% -$34.1K 0.07% 285
2016
Q2
$8.59M Sell
116,832
-1,967,321
-94% -$139M 0.06% 241
2016
Q1
$133M Buy
2,084,153
+1,958,802
+1,563% +$124M 0.96% 12
2015
Q4
$8.62M Sell
125,351
-1,289,232
-91% -$85.2M 0.06% 252
2015
Q3
$23.3M Buy
1,414,583
+976,508
+223% +$61.9M 0.14% 133
2015
Q2
$29.1M Sell
438,075
-337,358
-44% -$22.2M 0.19% 80
2015
Q1
$50M Sell
775,433
-485,317
-38% -$30.4M 0.3% 66
2014
Q4
$74.4M Buy
1,260,750
+333,403
+36% +$18.8M 0.37% 55
2014
Q3
$47.5M Sell
927,347
-142,290
-13% -$7.11M 0.28% 72
2014
Q2
$51.9M Sell
1,069,637
-511,191
-32% -$25.2M 0.3% 68
2014
Q1
$82.1M Sell
1,580,828
-603,235
-28% -$32.1M 0.36% 55
2013
Q4
$116M Buy
2,184,063
+486,050
+29% +$24.8M 0.48% 37
2013
Q3
$78.6M Sell
1,698,013
-899,647
-35% -$39.5M 0.32% 64
2013
Q2
$116M Buy
+2,597,660
New +$113M 0.57% 32

Other funds holding BMY

SG Americas Securities's BMY Position: Q1 2026 in Review

SG Americas Securities increased its Bristol-Myers Squibb (BMY) stake by 240% in Q1 2026, buying an estimated $366M and bringing the position to 8,910,032 shares worth $540M. The position accounts for 0.58% of the portfolio, ranked #23.

SG Americas Securities first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • SG Americas Securities held 8,910,032 shares of Bristol-Myers Squibb worth $540M as of Q1 2026.
  • SG Americas Securities bought 6,286,007 Bristol-Myers Squibb shares in Q1 2026, an estimated $366M.
  • Bristol-Myers Squibb made up 0.58% of SG Americas Securities's portfolio in Q1 2026, its #23 holding.
  • SG Americas Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.